Search for: "Teva Pharmaceuticals"
Results 41 - 60
of 1,422
Sort by Relevance
|
Sort by Date
17 Aug 2023, 9:00 pm
Tobolowsky —In January 2023, Vanda Pharmaceuticals, Inc. [read post]
15 Aug 2023, 4:29 am
Jane LambertCourt of Appeal (Lords Justices Arnold and Stuart-Smith and Lady Justice Falk) Teva Pharmaceutical Industries Ltd and another v Astellas Pharma Inc [2023] EWCA Civ 880 (25 July 2023) This was an appeal against the dismissal of the claim by Teva Pharmaceutical Industries Ltd. and Teva UK Ltd. [read post]
2 Aug 2023, 7:00 am
X’s commercial initiative is in direct correlation with the fact that, pursuant to the regulation in force, in September 2011, a “homogeneous group” (Nº 2634) for raloxifene medicines authorized in Spain was created, in accordance with the regulatory framework of the pharmaceutical sector, that is, for both original Evista® and Optruma® products manufactured by Daiichi and Esteve, and for raloxifene manufactured by Teva. [read post]
2 Aug 2023, 2:14 am
On appeal, Teva and Sandoz contended that the judge had erred in the application of the law as to obviousness. [read post]
31 Jul 2023, 12:48 pm
This case provides an interesting look at the application of the obviousness standard to pharmaceutical treatment methods. [read post]
25 Jul 2023, 1:43 am
Or that the credibility of the technical effect is assessed at the priority or filing date (e.g., TGI Paris, October 6, 2009, RG n°07/16446, Teva v. [read post]
21 Jul 2023, 4:47 pm
Teva Pharmaceuticals USA, Inc., No. 1:20-cv-11548 (D. [read post]
6 Jul 2023, 2:55 am
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
3 Jul 2023, 8:12 am
I haven't seen much discussion of this verdict handed down by a federal jury on Friday out in California that cleared the two pharmaceutical companies of antitrust liability. [read post]
27 Jun 2023, 7:32 pm
Teva Pharmaceuticals USA, Inc. [read post]
21 Jun 2023, 9:01 pm
Teva Pharmaceuticals USA, Inc. [read post]
20 Jun 2023, 7:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
12 Jun 2023, 1:09 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
11 Jun 2023, 8:17 pm
Teva Pharmaceuticals USA, Inc. [read post]
18 May 2023, 8:01 am
Most surprisingly to me, the court denied review in Teva Pharmaceuticals USA, Inc. v. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
15 May 2023, 1:00 pm
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
15 May 2023, 1:00 pm
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
